AzTrials
AzTrials

Acetabular Labrum TearNCT04953598

Ultrasonic Measurement of the Area of the Anterior Superior Labrum of the Hip Joint for Diagnosis of Labrum Tear

An observational study of Acetabular Labrum Tear, run by Peking University Third Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, ultrasound diagnosis was performed for patients with hip joint anterior superior labrum tear, and the final surgical observation was used as the gold standard to evaluate the diagnostic efficacy of ultrasonic measurement of the hip joint anterior superior labrum area in the diagnosis of labrum tear. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acetabular Labrum Tear
What is being tested?
Ultrasonography
How many people
160 participants
Where
1 siteChina
Study dates
29 Jul 2018to 5 Feb 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Case group: Outpatient Department of Sports Medicine, Peking University Third Hospital, clinically diagnosed patients with hip joint labrum tear, preoperative ultrasound examination. Control group: Patients who came to our hospital's ultrasound department at the same time for non-hip joint reasons matched by age, gender and case group.

Who may be able to join

  • Case group inclusion criteria (1) Age is greater than or equal to 18 years old (2) Patients with preoperative ultrasound examination for clinically planned hip joint anterior superior labrum tear (3) The patient can understand and sign the informed consent form Control group inclusion criteria
  • Age is greater than or equal to 18 years old
  • Patients who come to the ultrasound department of our hospital for treatment of non-hip joints at the same time
  • The patient can understand and sign the informed consent form

Who cannot join

  • Case group exclusion criteria
  • Mental conditions are not allowed
  • Adhesives that are allergic to any known Control group exclusion criteria
  • Mental conditions are not allowed (2) Adhesives that are allergic to any known (3) Past and current diseases of other hip joint diseases

Trial locations and contacts

1 site in 1 country.

China1 site
  • Department of Ultrasound Diagnosis, Peking University Third Hospital

    Beijing, Beijing Municipality

Other trials in China

About this study

In this study, ultrasound diagnosis was performed for patients with hip joint anterior superior labrum tear, and the final surgical observation was used as the gold standard to evaluate the diagnostic efficacy of ultrasonic measurement of the hip joint anterior superior labrum area in the diagnosis of labrum tear.

Read the detailed description

In this study, ultrasound diagnosis was performed for patients with a torn anterior superior labrum of the hip joint, and the final surgical observation was the gold standard. The control group selected patients with non-hip joint reasons to come to the ultrasound department of our hospital for diagnosis at the same time. Both the case group and the control group were included in the study at a rate of 1.1 times. This study plans to include 149 cases in the case group and 297 cases in the control group. This study was used to evaluate the diagnostic efficacy of ultrasonic measurement of the area of the anterior superior labrum of the hip in the diagnosis of labrum tears.

Being tested
Ultrasonography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • UltrasonographyDiagnostic test

    Patient undergoes diagnostic ultrasound examination

Study groups in NCT04953598
Study groupRoleWhat they receive
acetabular labrum tearsPatients with clinically diagnosed acetabular labrum tears
Receives: Diagnostic Test: Ultrasonography
Patients with non-hip injuriesFor non-hip joint reasons, come to the ultrasound department of our hospital to diagnose patients at the same time, and exclude other past and current hip diseases
Receives: Diagnostic Test: Ultrasonography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ultrasound diagnosis result image

    Ultrasound diagnosis as hip joint anterior superior labrum tear

    Measured: ultrasound diagnosis were preformed with hip arthroscopy at the same 1 day visiting time point

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2021
  2. Study start29 Jul 2018
  3. Primary completion14 Dec 2019
  4. Study completion5 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04953598
Sponsor's protocol ID
M2018106
Status last verified
Jun 2021
First submitted
27 Jun 2021
Last updated
8 Jul 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acetabular Labrum Tear, run by Peking University Third Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ultrasound diagnosis result image (time frame: ultrasound diagnosis were preformed with hip arthroscopy at the same 1 day visiting time point). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in